Tourmaline Bio Inc’s filing revealed that its CEO Kulkarni Sandeep Chidambar acquired Company’s shares for reported $26418.0 on Aug 21 ’24. In the deal valued at $14.85 per share,1,779 shares were bought. As a result of this transaction, Kulkarni Sandeep Chidambar now holds 7,000 shares worth roughly $0.16 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Kulkarni Sandeep Chidambar bought 5,221 shares, generating $71,998 in total proceeds. Upon buying the shares at $13.79, the CEO now owns 5,221 shares.
Before that, MCDADE MARK bought 100,000 shares. Tourmaline Bio Inc shares valued at $3,250,000 were divested by the Director at a price of $32.50 per share. As a result of the transaction, MCDADE MARK now holds 448,431 shares, worth roughly $10.32 million.
Jefferies initiated its Tourmaline Bio Inc [TRML] rating to a Buy in a research note published on December 15, 2023; the price target was $41. Truist began covering TRML with “Buy” recommendation on November 17, 2023. Guggenheim started covering the stock on October 31, 2023. It rated TRML as “a Buy”.
Price Performance Review of TRML
On Friday, Tourmaline Bio Inc [NASDAQ:TRML] saw its stock jump 1.86% to $23.02. Over the last five days, the stock has gained 19.46%. Tourmaline Bio Inc shares have fallen nearly -12.07% since the year began. Nevertheless, the stocks have fallen -19.51% over the past one year. While a 52-week high of $48.31 was reached on 03/13/24, a 52-week low of $9.18 was recorded on 07/05/24. SMA at 50 days reached $16.31, while 200 days put it at $22.33.
Levels Of Support And Resistance For TRML Stock
The 24-hour chart illustrates a support level at 22.08, which if violated will result in even more drops to 21.15. On the upside, there is a resistance level at 24.02. A further resistance level may holdings at 25.02. The Relative Strength Index (RSI) on the 14-day chart is 75.37, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.63, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 11.98%. Stochastics %K at 88.75% indicates the stock is a selling.
How much short interest is there in Tourmaline Bio Inc?
A steep rise in short interest was recorded in Tourmaline Bio Inc stocks on 2024-08-30, growing by 2589.0 shares to a total of 2.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 2.13 million shares. There was a rise of 0.12%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 25, 2023 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $65 price target.
